Clinical Trials Browser

Phase 1 × Chemotherapy-induced Peripheral Neuropathy × Clear all

NCT05251727 2024-08-19

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Phase 1 Terminated

Chemotherapy-induced Peripheral Neuropathy